
Quest Products expands portfolio with Doctor Butler’s acquisition
"This acquisition is a critical step in driving our Digestive Health platform and solidifying our leadership in the healthcare and OTC CPG industry," says Quest Products CEO.
"This acquisition is a critical step in driving our Digestive Health platform and solidifying our leadership in the healthcare and OTC CPG industry," says Quest Products CEO.
Women consistently spend nearly 30% more out of pocket on prescriptions than men, totaling $8.5 billion more in 2024 alone.
CVS Health uses GIS technology to rapidly track weather events and support health and health care, including uninterrupted access to medications, education and resources.
Musslewhite brings to the board unique expertise in advanced analytics, data, and technology across the healthcare ecosystem. Ramakrishna is an experienced CEO and global technology leader with more than two decades of technology and business expertise
The study's authors stress that misleading promotion of medical tests can lead to overdiagnosis.
The legislation by Reps. Dunn and Mullin aims to cut red tape, expedite generic approvals, and save $800 million over a decade.
Remington Drug Company emphasizes importance of patient access to independent pharmacy care as FTC probe of PBMs continues.
“By whatever means, the consensus PBM reforms are long overdue and need to be enacted now. The negative impacts of inaction are mounting for Americans and for their pharmacies.”
Foundation announces $2 million in new Health Zones funding to support at-risk populations.
The company's initiative follows its sponsorship of a white paper by the Med Safety Board, which found that medication errors impact one in every 30 patients.
Senior vice president of member programs and services Jim Whitman is retiring from the National Association of Chain Drug Stores in June.
“From working with suppliers and retailers, to handling complex supply chain issues, to knowing the needs of the membership over the course of decades, Steve defines service to a truly member-driven trade association.”
In his new role, Andersen will lead the strategic direction of the North American Pharmacy Automation Sales teams, including both Inside and Outside Sales, as well as the Clinical Consultants.
Green is leaving One Medical to become CEO of National Research Corp. (NRC Health), a provider of health-care analytics and other services, the company said.
The much-anticipated biosimilars for ustekinumab, commonly known by its brand name Stelara, are set to hit the market in mid-2025.